Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 161

1.

c-Yes enhances tumor migration and invasion via PI3K/AKT pathway in epithelial ovarian cancer.

Jin Y, Huang M, Wang Y, Yi C, Deng Y, Chen Y, Jiang L, Wang J, Shen Q, Liu R, QinghuaXi.

Exp Mol Pathol. 2016 Aug;101(1):50-7. doi: 10.1016/j.yexmp.2016.06.002. Epub 2016 Jun 8.

PMID:
27289010
2.

IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma.

Wan X, Yeung C, Heske C, Mendoza A, Helman LJ.

Neoplasia. 2015 Apr;17(4):358-66. doi: 10.1016/j.neo.2015.03.001.

3.

Yes is a central mediator of cell growth in malignant mesothelioma cells.

Sato A, Sekine M, Virgona N, Ota M, Yano T.

Oncol Rep. 2012 Nov;28(5):1889-93. doi: 10.3892/or.2012.2010. Epub 2012 Sep 3.

PMID:
22948717
4.

Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3.

Hamamura K, Tsuji M, Hotta H, Ohkawa Y, Takahashi M, Shibuya H, Nakashima H, Yamauchi Y, Hashimoto N, Hattori H, Ueda M, Furukawa K, Furukawa K.

J Biol Chem. 2011 May 27;286(21):18526-37. doi: 10.1074/jbc.M110.164798. Epub 2011 Mar 31.

5.

Differential expression of Yes-associated protein is correlated with expression of cell cycle markers and pathologic TNM staging in non-small-cell lung carcinoma.

Kim JM, Kang DW, Long LZ, Huang SM, Yeo MK, Yi ES, Kim KH.

Hum Pathol. 2011 Mar;42(3):315-23. doi: 10.1016/j.humpath.2010.08.003. Epub 2010 Dec 28.

PMID:
21190720
6.
7.

Crystallographic structure of the SH3 domain of the human c-Yes tyrosine kinase: loop flexibility and amyloid aggregation.

Martín-García JM, Luque I, Mateo PL, Ruiz-Sanz J, Cámara-Artigas A.

FEBS Lett. 2007 May 1;581(9):1701-6. Epub 2007 Mar 30.

8.

Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.

Nonomura T, Masaki T, Morishita A, Jian G, Uchida N, Himoto T, Izuishi K, Iwama H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.

Int J Oncol. 2007 Jan;30(1):105-11.

PMID:
17143518
9.

Activation of c-Yes in hepatocellular carcinoma: a preliminary study.

Feng H, Masaki T, Nonomura T, Morishita A, Jian G, Nakai S, Deguchi A, Uchida N, Himoto T, Iwama H, Usuki H, Wakabayashi H, Izuishi K, Yoshiji H, Kurokohchi K, Kuriyama S.

World J Gastroenterol. 2006 Sep 21;12(35):5743-5. No abstract available.

10.

Specificity in signaling by c-Yes.

Summy JM, Sudol M, Eck MJ, Monteiro AN, Gatesman A, Flynn DC.

Front Biosci. 2003 Jan 1;8:s185-205. Review.

PMID:
12456296
12.

Nakahara memorial lecture. Non-receptor type protein-tyrosine kinases closely related to src and yes compose a multigene family.

Toyoshima K, Semba K, Nishizawa M, Yamanashi Y, Sukegawa J, Miyajima N, Yamamoto T.

Princess Takamatsu Symp. 1986;17:11-20. Review.

PMID:
3332005
13.

Location of the c-yes gene on the human chromosome and its expression in various tissues.

Semba K, Yamanashi Y, Nishizawa M, Sukegawa J, Yoshida M, Sasaki M, Yamamoto T, Toyoshima K.

Science. 1985 Mar 1;227(4690):1038-40.

PMID:
2983418
14.

Characterization of cDNA clones for the human c-yes gene.

Sukegawa J, Semba K, Yamanashi Y, Nishizawa M, Miyajima N, Yamamoto T, Toyoshima K.

Mol Cell Biol. 1987 Jan;7(1):41-7.

15.

Expression of cellular-yes protein in mammalian tissues.

Zhao YH, Krueger JG, Sudol M.

Oncogene. 1990 Nov;5(11):1629-35.

PMID:
2267131
16.

Differential expression of p62c-yes in normal, hyperplastic and neoplastic human epidermis.

Krueger J, Zhao YH, Murphy D, Sudol M.

Oncogene. 1991 Jun;6(6):933-40.

PMID:
2067846
17.

YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.

Fan PD, Narzisi G, Jayaprakash AD, Venturini E, Robine N, Smibert P, Germer S, Yu HA, Jordan EJ, Paik PK, Janjigian YY, Chaft JE, Wang L, Jungbluth AA, Middha S, Spraggon L, Qiao H, Lovly CM, Kris MG, Riely GJ, Politi K, Varmus H, Ladanyi M.

Proc Natl Acad Sci U S A. 2018 Jun 26;115(26):E6030-E6038. doi: 10.1073/pnas.1717782115. Epub 2018 Jun 6.

18.

MiR-199a suppresses prostate cancer paclitaxel resistance by targeting YES1.

Chen L, Cao H, Feng Y.

World J Urol. 2018 Mar;36(3):357-365. doi: 10.1007/s00345-017-2143-0. Epub 2017 Dec 4.

PMID:
29204706
19.

miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.

Fang Z, Yin S, Sun R, Zhang S, Fu M, Wu Y, Zhang T, Khaliq J, Li Y.

Mol Cancer. 2017 Aug 17;16(1):139. doi: 10.1186/s12943-017-0708-6.

20.

Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.

Tan W, Lim SG, Tan TM.

World J Gastroenterol. 2015 Dec 14;21(46):13030-41. doi: 10.3748/wjg.v21.i46.13030.

Supplemental Content

Support Center